HomeHKMPF • OTCMKTS
add
Hikma Pharmaceuticals Plc
Previous close
$22.56
Year range
$21.90 - $26.50
Market cap
4.33B GBP
Avg Volume
28.00
P/E ratio
-
Dividend yield
-
Primary exchange
LON
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 784.50M | 9.95% |
Operating expense | 177.00M | -12.81% |
Net income | 113.00M | 72.52% |
Net profit margin | 14.40 | 56.86% |
Earnings per share | — | — |
EBITDA | 249.50M | 11.88% |
Effective tax rate | 20.49% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 260.00M | -11.56% |
Total assets | 4.85B | 4.94% |
Total liabilities | 2.55B | 5.38% |
Total equity | 2.30B | — |
Shares outstanding | 221.75M | — |
Price to book | 2.19 | — |
Return on assets | 10.37% | — |
Return on capital | 14.05% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | 113.00M | 72.52% |
Cash from operations | 99.00M | -10.81% |
Cash from investing | -53.00M | 10.92% |
Cash from financing | -26.00M | 46.94% |
Net change in cash | 15.50M | 1,450.00% |
Free cash flow | 116.38M | 10.50% |
About
Hikma Pharmaceuticals plc is a British multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. It was founded by Samih Darwazah in Amman, Jordan in 1978. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index. Wikipedia
Founded
1978
Website
Employees
9,100
